A comparative study of two phakic posterior chamber implantable lenses
- PMID: 38758875
- PMCID: PMC11098212
- DOI: 10.1097/MD.0000000000038194
A comparative study of two phakic posterior chamber implantable lenses
Abstract
This study aimed to compare the postimplantation clinical outcomes of 2 types of posterior chamber phakic intraocular lenses (IOLs): Visian™ implantable collamer lenses (ICL; EVO+ V5; Staar Surgical, Monrovia, CA) and an implantable phakic contact lens (IPCL) (IPCL V2.0, Care Group Sight Solution, India) to correct high myopia and myopic astigmatism. This retrospective study included patients who had undergone phakic IOL implantation performed by a single surgeon between March 2021 and March 2022. Preoperative assessments included slit-lamp examination, fundus examination, spherical equivalent, uncorrected distant visual acuity (UDVA), corrected distant visual acuity (CDVA), specular microscope parameters, and optical quality analysis system parameters. Postoperative assessments after 1 year included slit-lamp examination to detect adverse effects and spherical equivalent, UDVA, CDVA, specular microscope, optical quality analysis system, and anterior-segment optical coherence tomography. Eighty eyes from 42 patients (47 eyes from 24 patients in the ICL group and 33 eyes from 18 patients in the IPCL group) were included. No statistically significant differences were observed between the 2 groups regarding preoperative parameters. At 1-year postoperatively, the mean UDVA in the ICL and IPCL groups was 0.019 ± 0.040 logMAR and 0.019 ± 0.041 logMAR, respectively. The mean CDVA was 0.001 ± 0.008 logMAR and 0.001 ± 0.007 logMAR in the ICL and IPCL groups, respectively, showing no statistically significant differences. The postoperative parameters did not differ significantly between the 2 groups. The visual acuity and refractive results of both groups were excellent, and both groups exhibited similar efficacy and safety profiles.
Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors have no funding and conflicts of interest to disclose.
Figures
Similar articles
-
Comparative analysis of clinical outcomes between two types of posterior chamber phakic intraocular lenses for correction of myopia and myopic astigmatism.Indian J Ophthalmol. 2019 Jul;67(7):1061-1065. doi: 10.4103/ijo.IJO_1501_18. Indian J Ophthalmol. 2019. PMID: 31238411 Free PMC article.
-
Comparison of clinical outcomes and vault between two types of posterior phakic intraocular lenses in correction of myopia and myopic astigmatism.Eur J Ophthalmol. 2025 Sep;35(5):1585-1592. doi: 10.1177/11206721251323642. Epub 2025 Mar 16. Eur J Ophthalmol. 2025. PMID: 40091356
-
Initial clinical outcomes of two different phakic posterior chamber IOLs for the correction of myopia and myopic astigmatism.Graefes Arch Clin Exp Ophthalmol. 2022 May;260(5):1763-1772. doi: 10.1007/s00417-021-05465-w. Epub 2021 Nov 6. Graefes Arch Clin Exp Ophthalmol. 2022. PMID: 34741659
-
Efficacy and Safety After Toric Posterior Chamber Implantable Collamer Lens and Toric Iris-Fixated Foldable Phakic Intraocular Lens for Myopic Astigmatism.J Refract Surg. 2022 Jun;38(6):339-347. doi: 10.3928/1081597X-20220406-01. Epub 2022 Jun 1. J Refract Surg. 2022. PMID: 35686710
-
EVO/EVO+ Visian Implantable Collamer Lenses for the correction of myopia and myopia with astigmatism.Expert Rev Med Devices. 2023 Feb;20(2):75-83. doi: 10.1080/17434440.2023.2174429. Epub 2023 Feb 10. Expert Rev Med Devices. 2023. PMID: 36708714 Review.
References
-
- Holden BA, Fricke TR, Wilson DA, et al. . Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123:1036–42. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources